Page 143 - Biomarkers for risk stratification and guidance in heart failure

Chapter 6
REFERENCES
1. McAlister FA, Ezekowitz J, Tarantini L et al. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula. Circulation Heart failure 2012;5:309-14.
2. Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of the kidney in heart failure. European heart journal 2012;33:2135-42.
3. Nohria A, Hasselblad V, Stebbins A et al. Cardiorenal interactions: insights from the ESCAPE trial. Journal of the American College of Cardiology 2008;51:1268-74.
4. Fonarow GC, Adams KF, Jr., Abraham WT et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA : the journal of the American Medical Association 2005;293:572-80.
5. Hillege HL, Girbes AR, de Kam PJ et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102:203-10.
6. Blair JE, Pang PS, Schrier RW et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. European heart journal 2011;32:2563-72.
7. Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. European heart journal 2014;35:455-69.
8. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168- 74.
9. O’Brien RJ, Squire IB, Demme B, Davies JE, Ng LL. Pre-discharge, but not admission, levels of NT- proBNP predict adverse prognosis following acute LVF. European journal of heart failure 2003;5:499- 506.
10. Eurlings LW, Sanders-van Wijk S, van Kraaij DJ et al. Risk-stratification by serial NT-proBNP measurements during admission and early after discharge in heart failure patients. Journal of cardiac failure 2014.
11. Masson S, Latini R, Anand IS et al. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). Journal of the American College of Cardiology 2008;52:997-1003.
12. Eurlings LW, van Pol PE, Kok WE et al. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide-guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. Journal of the American College of Cardiology 2010;56:2090-100.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine 1999;130:461-70.
14. Metra M, Davison B, Bettari L et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circulation Heart failure 2012;5:54-62.
15. Gottlieb SS, Abraham W, Butler J et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. Journal of cardiac failure 2002;8:136-41.
16. Maeder MT, Rickli H, Pfisterer ME et al. Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. American heart journal 2012;163:407-14, 414 e1.
17. Testani JM, McCauley BD, Chen J, Coca SG, Cappola TP, Kimmel SE. Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure. Journal of cardiac failure 2011;17:993-1000.
18. Testani JM, McCauley BD, Kimmel SE, Shannon RP. Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. The American journal of cardiology 2010;106:1763-9.
142